Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,015,467 papers from all fields of science
Search
Sign In
Create Free Account
FAH gene
Known as:
FUMARYLACETOACETASE
, fumarylacetoacetate hydrolase (fumarylacetoacetase)
, FUMARYLACETOACETATE HYDROLASE
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
FAHD2A gene
Fumarylacetoacetase
Tyrosinemia, Type I
Broader (1)
Genes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The Somatic FAH c.1061C>A Change Counteracts the Frequent FAH c.1062+5G>A Mutation and Permits U1snRNA-Based Splicing Correction
Daniela Scalet
,
Claudia Sacchetto
,
F. Bernardi
,
M. Pinotti
,
S. V. D. van de Graaf
,
D. Balestra
Journal of Human Genetics
2018
Corpus ID: 3609912
In tyrosinaemia type 1(HT1), a mosaic pattern of fumarylacetoacetase (FAH) immunopositive or immunonegative nodules in liver…
Expand
2004
2004
X-ray structure of fumarylacetoacetate hydrolase family member Homo sapiens FLJ36880
B. Manjasetty
,
F. Niesen
,
+5 authors
U. Heinemann
Biological chemistry
2004
Corpus ID: 16759973
Abstract The human protein FLJ36880 belongs to the fumarylacetoacetate hydrolase family. The X-ray structure of FLJ36880 has been…
Expand
2002
2002
The crystal structure of HpcE, a bifunctional decarboxylase/isomerase with a multifunctional fold.
J. Tame
,
K. Namba
,
E. Dodson
,
D. Roper
Biochemistry
2002
Corpus ID: 31598539
The structure of the bifunctional enzyme HpcE (OPET decarboxylase/HHDD isomerase) from Escherichia coli shows that the protein…
Expand
Highly Cited
1994
Highly Cited
1994
A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
M. Grompe
,
M. St‐Louis
,
S. I. Demers
,
M. Al‐Dhalimy
,
Barbara Leclerc
,
R. Tanguay
New England Journal of Medicine
1994
Corpus ID: 21764822
BACKGROUND Hereditary tyrosinemia type I is an autosomal recessive inborn error of metabolism caused by a deficiency of the…
Expand
1993
1993
Localization of cells in the rat brain expressing fumarylacetoacetate hydrolase, the deficient enzyme in hereditary tyrosinemia type 1.
Y. Labelle
,
J. Puymirat
,
R. Tanguay
Biochimica et Biophysica Acta
1993
Corpus ID: 45964867
1987
1987
Type I Tyrosinemia: Lack of Immunologically Detectable Fumarylacetoacetase Enzyme Protein in Tissues and Cell Extracts
R. Berger
,
H. Faassen
,
J. Taanman
,
H. Vries
,
E. Agsteribbe
Pediatric Research
1987
Corpus ID: 38218242
ABSTRACT. Type I hereditary tyrosinemia is characterized by the almost complete absence of fumarylacetoacetase in tissues and…
Expand
1986
1986
The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
E. Kvittingen
,
E. Brodtkorb
Scandinavian journal of clinical and laboratory…
1986
Corpus ID: 20842323
Fumarylacetoacetase has been determined in fibroblasts, lymphocytes and/or liver tissue from 46 patients affected or presumed to…
Expand
1983
1983
Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
S. K. Wadman
,
M. Durán
,
+9 authors
B. Cartigny
Clinica chimica acta; international journal of…
1983
Corpus ID: 25485635
Highly Cited
1981
Highly Cited
1981
Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Rudolphus Berger
,
Gerrit Smit
,
Sa Stokerdevries
,
Marinus Duran
,
D. Ketting
,
S. Wadman
Clinica chimica acta; international journal of…
1981
Corpus ID: 12543453
1979
1979
Hereditary tyrosinemia - fumarylacetoacetase deficiency
S. -. Fällström
,
B. Lindblad
,
S. Lindstedt
,
G. Steen
Pediatric Research
1979
Corpus ID: 52859369
Succinylacetone which has been isolated from urine from patients with hereditary tyrosinemia inhibits porphobilinogen synthase…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE